7 Biotechnology Stocks With Insider Buying Activity

Biotech stocks can provide sudden and magnificent returns, but they can be just as unforgiving. How can you decide which biotech stocks are worth investing in then? We looked into it further: 

We ran a screen of biotech stocks that are showing insider buying. If anyone knows what is going on with a company, it has to be the people that work there.  [Related list:  Bullish Trinity: Stocks with Short Covering, Insider & Hedge Fund Buying ]

Many analysts follow insider buying trends exactly for that reason. Their transactions are closely monitored and can tell us a lot about where the business is heading.

Business Section: Investing Ideas

If insiders are buying the stock of the biotech company they’re working for, then they have to either think that the stock is undervalued or that something big is going to happen, such as a drug receiving FDA approval.

Below is the final list from our screen. It shows biotech companies with market caps over $50 million and insider buying over the past six months. Do you think the insiders know something that nobody else does?

Use this list as a starting point for your own analysis. 

1. Amyris, Inc. (AMRS , Earnings , Analysts , Financials ): An integrated renewable products company, offers renewable compounds for a variety of markets. Market cap at $217.5M.

Over the last six months, insiders were net buyers of 4,718,990 shares, which represents about 16.89% of the company's 27.94M share float.
 

2. Infinity Pharmaceuticals, Inc. (INFI, Earnings, Analysts, Financials): Engages in the discovery and development of medicines for the treatment of cancer and other conditions in the United States. Market cap at $2.34B.

Over the last six months, insiders were net buyers of 5,380,195 shares, which represents about 18.43% of the company's 29.19M share float.
 

3. Lexicon Pharmaceuticals, Inc. (LXRX, Earnings, Analysts, Financials): Focuses on the discovery and development of drug candidates for the treatment of various human diseases. Market cap at $1.11B.

Over the last six months, insiders were net buyers of 3,000,000 shares, which represents about 1.32% of the company's 227.31M share float.
 

4. MannKind Corp. (MNKD, Earnings, Analysts, Financials): Focuses on the discovery, development, and commercialization of therapeutic products for diabetes and cancer. Market cap at $972.54M.

Over the last six months, insiders were net buyers of 39,997,650 shares, which represents about 32.04% of the company's 124.82M share float.
 

5. Pacific Biosciences of California, Inc. (PACB, Earnings, Analysts, Financials): Develops, manufactures, and markets an integrated platform for genetic analysis. Market cap at $124.11M.

Over the last six months, insiders were net buyers of 1,400,000 shares, which represents about 4.26% of the company's 32.84M share float.
 

6. Targacept, Inc. (TRGT, Earnings, Analysts, Financials): Engages in the design, discovery, and development of novel Neuronal Nicotinic Receptors (NNR) Therapeutics for the treatment of diseases and disorders of the central nervous system. Market cap at $148.22M.

Over the last six months, insiders were net buyers of 2,023,840 shares, which represents about 8.88% of the company's 22.78M share float.
 

7. XOMA Corporation (XOMA): Engages in the discovery, development, and manufacture of therapeutic antibodies to treat inflammatory, autoimmune, infectious, and oncological diseases. Market cap at $274.23M.

Over the last six months, insiders were net buyers of 4,722,670 shares, which represents about 9.76% of the company's 48.41M share float.
 

( List compiled by Rebecca Lipman, Kapitall Editor )

 

null

If you liked this article you might like

Mattel CEO Georgiadis Expected to Drive Tech Growth

Demand for Aviation Biofuels Grows as Green Regulations Loom

Demand for Aviation Biofuels Grows as Green Regulations Loom

7 Stocks Under $10 to Trade for Big Profits

6 Stocks Under $10 to Trade for Breakouts

3 Stocks Improving Performance Of The Chemicals Industry